Researchers linked a family’s novel LPL variant to impaired LPL release, although they did not diagnose any family members ...

Pediatric patients with mtARS disorders who received amino acid supplementation showed improvement, justifying larger studies ...

Across follow-up, tirzepatide exposure was associated with fewer major adverse liver outcomes and hospitalizations in ...

Patients with concurrent PBC and osteoporosis do not have an increased risk of major bone fracture vs patients with ...

Amgen Canada announced that inebilizumab is now available in the country as an add-on to standard therapy for adults with ...

A network meta-analysis found that rifampin ranked highest for change in pruritus score, followed by linerixibat, in patients ...

Seladelpar achieved the highest comparative ranking for biochemical response and ALP normalization in patients with PBC.

In a proof-of-concept study, deep red light therapy was well tolerated but did not improve ptosis in teenagers with ...

Anti-CD36 alloimmunization may contribute to severe platelet transfusion refractoriness despite negative human leukocyte ...

Nerandomilast treatment reduces fibrotic remodeling and modulates the dynamics of alveolar epithelial cell states, a study ...

Nearly 90% of patients with FSHD who developed myasthenia gravis (MG) improved with treatment, according to a new systematic ...

A 55-CpG DNA methylation signature stratified myelodysplastic syndrome (MDS) risk and predicted acute myeloid leukemia ...